R Danny Huntington began his career as a chemist at the Gillette Research Institute. Shortly after joining the institute, he became the patent liaison to outside patent counsel and later, to in-house attorneys at parent company, The Gillette Company. Finding the interface between technology and patent law fascinating, after earning his law degree he joined the patent staff of The Gillette Company, where he continued to represent the institute.
After entering private practice in Boston, Mr Huntington wrote and prosecuted some of the earliest-filed biotechnology patent applications. He was also involved in district court litigation and patent interferences, the latter primarily in the field of pharmaceuticals.
In 1981, he moved to the Washington, DC area and continued a varied practice until the US Patent and Trademark Office started declaring patent interferences involving biotechnology. Mr Huntington was one of the few attorneys knowledgeable in both interferences and biotechnology, and he soon found himself spending most of his time working in this field. His expertise in biotechnology interferences led him to handle interferences involving other technologies. He has now handled well over 200 interferences and he frequently lectures on interference practice.
In addition to traditional uses, Mr Huntington has promoted interferences as an alternative vehicle for defending against non-practicing entities, sometimes referred to as 'patent trolls'. This type of practice has transitioned readily into the new inter partes review (IPR) and post-grant review (PGR), since these are essentially the same as the first stage of an interference, with the possible addition of some discovery.
Mr Huntington's practice continues to include all phases of IP law, including US and foreign patent prosecution, litigation in the federal courts, licensing, and general client counselling. Having practiced both in-house and in private practice, he can provide advice that takes into account the various issues confronting rights holders.